Posted by Michael Wonder on 06 Feb 2023
Respiri becomes first Australian company to receive US reimbursements
6 February 2023 - The medical device manufacturer can now have its patented wheezo device, used for remote patient monitoring programs, receive reimbursement in America for patients who suffer from respiratory disorders.
Respiri has become the first Australian company to have its medical device receive reimbursement from Centres of Medicare and Medicaid Services in the US.
